Incidence of Parkinson's disease and Parkinsonism in northern Sweden: A population-based study

Movement Disorders

Volumn 25, Issue 3, 2010, Pages 341-348

  Linder, Jan ^a   Stenlund, Hans ^a   Forsgren, Lars ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Epidemiology; Incidence; Parkinson's disease; Parkinsonism; Population based

Indexed keywords

DOPAMINE RECEPTOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROSPECTIVE STUDY; SEX DIFFERENCE; SEX RATIO; SHY DRAGER SYNDROME; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY HEALTH PLANNING; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PARKINSONIAN DISORDERS; SUPRANUCLEAR PALSY, PROGRESSIVE; SWEDEN; YOUNG ADULT;

EID: 77649147743     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22987     Document Type: Article

References (28)

1. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003;18:19-31.
2. Dupont E. Epidemiology of parkinsonism. The Parkinson investigation, Aarhus, Denmark (preliminary results). In: Worm-Petersen J, Bottcher J, editors. Symposium on parkinsonism. Copenhagen: Merck Sharp and Dohme; 1977. p 65-75.
3. Fall PA, Axelson O, Fredriksson M, et al. Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. J Clin Epidemiol 1996;49:637-641.
4. Kuopio AM, Marttila RJ, Helenius H, Rinne UK. Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 1999;52:302-308.
5. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976;53:81-102.
6. Gudmundsson KR. A clinical survey of parkinsonism in Iceland. Acta Neurol Scand 1967;43(Suppl 33):31-61.
7. Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D, et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009; 80:851-857.
8. Wermuth L, Bech S, Petersen MS, Joensen P, Weihe P, Grand-jean P. Prevalence and incidence of Parkinson's disease in The Faroe Islands. Acta Neurol Scand 2008;118:126-131.
9. Taylor KS, Counsell CE, Harris CE, Gordon JC, Smith WC. Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results. Mov Disord 2006;21:976-982.
10. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004;127:550-560.
11. Fahn S, Elton RL,the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information; 1987. p 153-163.
12. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 1989;15:27-44.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
14. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
15. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996;47:1-9.
16. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee Report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-486.
17. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005;65:1863-1872.
18. Benamer HT, Oertel WH, Patterson J, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord 2003;18:977-984.
19. Statistics Sweden. Available at www.scb.se/Pages/ProductTables-25809. aspx.
20. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976-1990. Neurology 1999;52:1214-1220.
21. Leentjens AF, Van den Akker M, Metsemakers JF, Troost J. The incidence of Parkinson's disease in the Netherlands: results from a longitudinal general practice-based registration. Neuroepidemiology 2003;22:311-312.
22. Haaxma CA, Bloem BR, Borm GF, et al. Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007;78: 819-824.
23. Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-1130.
24. Caslake R, Moore JN, Gordon JC, Harris CE, Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatry 2008; 79:1202-1207.
25. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;49:1284-1288.
26. Benito-Leon J, Bermejo-Pareja F, Morales-Gonzalez JM, et al. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 2004;62:734-741.
27. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004;63:1240-1244.
28. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 2009;8:270-279.